Nirvana Life Sciences (XCNQ:NIRV) YoY EBITDA Growth : 100.00% (As of Jan. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Nirvana Life Sciences YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Nirvana Life Sciences's YoY EBITDA Growth for the quarter that ended in Jan. 2024 was 100.00%.

Nirvana Life Sciences's EBITDA per Share for the three months ended in Jan. 2024 was C$0.00.

Nirvana Life Sciences YoY EBITDA Growth Historical Data

The historical data trend for Nirvana Life Sciences's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nirvana Life Sciences YoY EBITDA Growth Chart

Nirvana Life Sciences Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Apr22

Apr23

YoY EBITDA Growth

Get a 7-Day Free Trial

125.00

-1,100.00

-1,420.00

73.03

Nirvana Life Sciences Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
YoY EBITDA Growth	Get a 7-Day Free Trial															-100.00	-	-12.50	42.86	100.00

Nirvana Life Sciences YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Nirvana Life Sciences's YoY EBITDA Growth for the fiscal year that ended in Apr. 2023 is calculated as:

	YoY EBITDA Growth (A: Apr. 2023 )
=	(EBITDA per Share (A: Apr. 2023 )	-	EBITDA per Share (A: Apr. 2022 ))	/	\| EBITDA per Share (A: Apr. 2022 ) \|
=	(-0.041	-	-0.152)	/	\| -0.152 \|
=	73.03 %

Nirvana Life Sciences's YoY EBITDA Growth for the quarter that ended in Jan. 2024 is calculated as:

	YoY EBITDA Growth (Q: Jan. 2024 )
=	(EBITDA per Share (Q: Jan. 2024 )	-	EBITDA per Share (Q: Jan. 2023 ))	/	\| EBITDA per Share (Q: Jan. 2023 )) \|
=	(0	-	-0.006)	/	\| -0.006 \|
=	100.00 %

Nirvana Life Sciences YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Nirvana Life Sciences's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Nirvana Life Sciences (XCNQ:NIRV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nirvana Life Sciences Inc (XCNQ:NIRV) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8

Website

https://www.nirvanalifescience.com

Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.

Nirvana Life Sciences (XCNQ:NIRV) Headlines

No Headlines